Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Dec 7;14(12):e246274.
doi: 10.1136/bcr-2021-246274.

Complete splenic infarction in association with COVID-19

Graham Prentice  1 , Stephen Wilson  2 , Alexander Coupland  3 , Stephen Bicknell  2
Affiliations
Case Reports

Complete splenic infarction in association with COVID-19

Graham Prentice et al. BMJ Case Rep. .

Abstract

COVID-19 predominantly affects the respiratory system. As a novel disease, understanding of its management and complications continues to grow. Herein, we present a case of almost complete splenic infarction in a patient with COVID-19 pneumonia. This case highlights the need to maintain diagnostic vigilance whilst investigating secondary complications of COVID-19. It is also important to stress the high incidence of thromboembolic complications in patients with COVID-19, which may occur anywhere in the vasculature.

Keywords: COVID-19; radiology; respiratory medicine.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Posteroanterior chest radiograph on admission. Bilateral predominantly peripheral and basal pulmonary infiltrates in keeping with COVID-19 pneumonia.
Figure 2
Figure 2
CT abdomen arterial phase imaging demonstrates thromboembolic material within the splenic artery (indicated by arrow) causing near complete splenic infarction.
Figure 3
Figure 3
CT chest demonstrating bibasal and peripheral ground glass opacification and patchy more confluent consolidation in keeping with COVID-19 pneumonia.
See this image and copyright information in PMC

References

    1. Grant MC, Geoghegan L, Arbyn M, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PLoS One 2020;15:e0234765. 10.1371/journal.pone.0234765 - DOI - PMC - PubMed
    1. Malas MB, Naazie IN, Elsayed N, et al. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. EClinicalMedicine 2020;29:100639–30. 10.1016/j.eclinm.2020.100639 - DOI - PMC - PubMed
    1. et alBagot C, Miles B, Chalmers G. Prevention of thrombosis in COVID-19 +ve adult inpatients (pregnant and non-pregnant) undergoing renal replacement therapy (RRT) on critical care wards. NHS greater Glasgow and Clyde Staffnet. Available: http://www.staffnet.ggc.scot.nhs.uk/Acute/Surgery%20Anaesthetics/Critica... [Accessed 17 Feb 2021].
    1. Marietta M, Coluccio V, Luppi M. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern Emerg Med 2020;15:1375–87. 10.1007/s11739-020-02432-x - DOI - PMC - PubMed
    1. Abou-Ismail MY, Diamond A, Kapoor S, et al. The hypercoagulable state in COVID-19: incidence, pathophysiology, and management. Thromb Res 2020;194:101–15. 10.1016/j.thromres.2020.06.029 - DOI - PMC - PubMed

Publication types